Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
Bipolar Disorder
About this trial
This is an interventional treatment trial for Bipolar Disorder focused on measuring bipolar disorder, manic episode, treatment, licarbazepine
Eligibility Criteria
Inclusion Criteria: Diagnosis of bipolar disorder (type I) with manic or mixed episodes (including patients with/without psychotic features or with/without a history of rapid cycling) In need of psychiatric treatment Cooperation and willingness to complete all aspects of the study Exclusion Criteria: Current diagnosis other than bipolar I disorder History of schizophrenia or schizoaffective disorder Drug dependence within 1 month prior to study start or testing positive in a urine drug test Suicide attempt within 1 month prior to study start or at immediate risk of harm to self or others Any form of psychotherapy within 1 month prior to study start
Sites / Locations
- Investigational Site
- Investigational Site
- Investigational Site
- Investigational Site
- Investigational Site
- Investigational Site
- Investigational Site
- Investigational Site
- Investigational Site
- Investigational Site
- Investigational Site
- Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis investigator site
- Novartis investigator site
- Novartis investigator site
- Novartis investigator site
- Novartis investigator site
- Guatemala
- Guatemala
- Guatemala
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
- Novartis Investigational Site
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
licarbazepine
Placebo